Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06887283 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Essen Amyloidosis Registry

Study acronym: EAR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to improve the understanding of disease progression, diagnostic pathways, and treatment outcomes. The registry is hosted at the University Hospital Essen and follows patients longitudinally. Inclusion is open to all patients with suspected or confirmed amyloidosis who provide informed consent.
Trial Details
NCT Number NCT06887283
Lead Sponsor University Hospital, Essen
Conditions
(from sponsor)		 Amyloidosis; Systemic, Amyloidosis Cardiac
Related terms Amyloid Neuropathies, Familial, Amyloidosis, Cardiomyopathies, Immunoglobulin Light-chain Amyloidosis
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov